Biotech

All Articles

Daiichi spends Merck $170M to develop lung cancer T-cell engager contract

.Merck &amp Co. has actually quickly made back several of the costs of its own Weapon Rehabs acquist...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin administered a springtime clean of its own pipeline in April, the firm has actually ...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Big Pharmas remain stuck to the concept of molecular glue degraders. The most recent company to fin...

Life science credit score company unveils with $600M

.A brand new global life science credit scores firm, nicknamed Symbiotic Funding, has increased more...

BMS channels TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another major bet coming from the Caforio era, canceling...

Nuvation stops wager prevention after considering phase 1 data

.After taking a look at period 1 record, Nuvation Bio has actually determined to stop service its si...

' Clinical intuitiveness' led FDA consultants to support Zevra's rare condition med

.Zevra Therapies' rare health condition medication seems to become on the path to permission this au...

Pfizer takes $230M hit after axing neglected DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has actually blown a $230...

AC Immune views 'spots' potential in Alzheimer's medication records

.After much more than two decades of deal with neurodegenerative health conditions, Swiss biotech hv...

GSK goes down ph. 2 HPV vaccination over lack of best-in-class possible

.GSK has scrapped a period 2 individual papillomavirus (HPV) vaccination from its pipeline after det...